Otros idiomas Tianda Pharmaceuticals Limited

Acciones

455 KYG887471038

Farmacéuticos

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 09:08:04 06/02/2026			Variación 5 días	Varia. 1 de enero.
0,1010 ^HKD	0,00 %		0,00 %	-21,71 %

28/08/25	Tianda Pharmaceuticals Limited Anuncia la Renuncia del Sr. Feng Quanming como Director No Ejecutivo, Efectiva a partir del 29 de agosto de 2025	CI
28/08/25	Tianda Pharmaceuticals Limited presenta resultados financieros del primer semestre finalizado el 30 de junio de 2025	CI

Otros idiomas

28/08/25	Tianda Pharmaceuticals Limited Announces Resignation of Mr. Feng Quanming as a Non-Executive Director of the Company, Effective 29 August 2025
28/08/25	Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2025
27/06/25	Tianda Pharmaceuticals Limited Announces Board and Committee Changes, Effective June 27, 2025
28/03/25	Tianda Pharmaceuticals Limited Recommends No Final Dividend for the Year Ended 31 December 2024
28/03/25	Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2024
25/03/25	Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
25/03/25	Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2024
28/08/24	Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2024
22/08/24	Tianda Pharmaceuticals Warns of Wider H1 Loss
22/08/24	Tianda Pharmaceuticals Limited Provides Unaudited Consolidated Earnings Guidance for the Six-Month Period from 1 January 2024 to 30 June 2024
11/06/24	Tianda Pharma Unit's Ibuprofen Gets Approval in China
11/06/24	Tianda Pharmaceutical Technology Co., Ltd. Receives Drug Registration Approval of Ibuprofen Suspension
07/06/24	Tianda Pharmaceuticals Limited Approves Final Dividend
16/05/24	Tianda Pharmaceuticals Unit Gets Registration Go-Ahead for Acute Coronary Drug from Chinese Regulator
26/03/24	Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
26/03/24	Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
21/03/24	Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023
28/08/23	Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023
28/08/23	Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023
24/08/23	Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%
23/08/23	Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023
02/08/23	Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical
01/08/23	Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.
27/06/23	Tianda Pharmaceuticals Limited Announces Board Changes
27/06/23	Tianda Pharmaceuticals Limited Approves Final Dividend

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas Tianda Pharmaceuticals Limited

Acciones

455

KYG887471038

Farmacéuticos

Otros idiomas

Filtros